Man seeking immortality diagnosed with incurable disease
July 7 2026
Millionaire entrepreneur and self-described biohacker Bryan Johnson, who has spent millions of dollars in an ambitious effort to slow aging and extend human life, has revealed that he has been diagnosed with autoimmune gastritis an incurable condition in which the body’s immune system mistakenly attacks the lining of the stomach.
Johnson, founder of the anti-aging initiative known as Blueprint, disclosed the diagnosis in a recent update, describing it as an unexpected setback in his years-long pursuit of optimal health. The condition causes chronic inflammation of the stomach lining and can interfere with the body’s ability to absorb essential nutrients, including vitamin B12 and iron. Left unmanaged, it may increase the risk of anemia and, in some cases, stomach cancer.
The diagnosis comes as a striking twist for the 48-year-old tech entrepreneur, who has become one of the world’s most recognizable figures in the longevity movement. Johnson reportedly spends millions of dollars annually on an intensive health regimen involving constant medical monitoring, strict nutrition, daily exercise, experimental therapies, and dozens of supplements aimed at slowing biological aging.
He previously attracted global attention after revealing that he underwent plasma transfusions using blood donated by his teenage son as part of an experimental longevity protocol. The procedure generated widespread debate within the scientific and medical communities, and Johnson later confirmed he had discontinued the practice after finding no measurable benefits.
Autoimmune gastritis currently has no cure. Treatment is generally focused on monitoring the condition, managing symptoms, correcting nutritional deficiencies, and screening for potential complications. Medical experts note that while the disease cannot be reversed, many people are able to live healthy lives with appropriate medical care and regular follow-up.
Despite the diagnosis, Johnson has indicated that he remains committed to his mission of improving human health and longevity through science, while using the experience to better understand the complexities of the human body.
Johnson’s journey has become one of the most closely watched experiments in modern longevity research, highlighting both the promise and the limitations of cutting-edge health optimization. His latest diagnosis serves as a reminder that even with extensive resources, advanced medical technology, and rigorous health monitoring, some diseases remain beyond the reach of current medical science.
